Dear Vascular Biology Community,
On behalf of the Organizing Committee, I am delighted to announce that IVBM 2016 will take place in Boston, Massachusetts. The meeting will be held at the Sheraton Boston Hotel between October 30 and November 3. The goal of the meeting is to provide a forum for investigators and trainees from around the world to share and exchange ideas related to cutting edge research in vascular biology. The meeting will be organized around four themes that will run as simultaneous sessions: 1) Diseases, 2) Cells and Vascular Beds, 3) Cellular Processes, and 4) Emerging Topics. With the help of our distinguished International Scientific Program Committee, we have identified a broad range of topics for each of these themes. Each topic/session will feature two talks from internationally recognized experts and two short talks chosen from submitted abstracts. In addition to these sessions, the meeting will include plenary sessions and award talks. Other features planned for the meeting include Meet the Professor Breakfasts, poster sessions, exhibit program, and career development sessions.
The rosters for the Organizing and Program Committees as well as the preliminary agenda for the meeting are posted here, select the appropriate menu item on the left.
We look forward to seeing you all in 2016!
William C. Aird, M.D.
Harvard Medical School
Abstract Deadline is July 26, 2016
Over 75 abstracts will be chosen for short talks!
Submission site is now open!
Registration site is now open!
Can't open a flash file - click here
Download the app
Currently includes the Preliminary Program and Speakers
Search for NAVBO Events in the Apple and Android stores or use the appropriate QR code:
Funding for this conference was made possible (in part) by 1R13HL132522-01 from the National Institutes of Health. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.